Entrada Therapeutics Inc (NAS:TRDA)
$ 5.84 -0.20 (-3.31%) Market Cap: 226.91 Mil Enterprise Value: 195.93 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 35/100

Entrada Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 07:30 PM GMT
Release Date Price: $11.85 (+1.46%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TRDA.OQ - Entrada Therapeutics Inc
Entrada Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 07:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you everyone in the room and online for joining us at the 46th annual TD Cowan Healthcare Conference. I'm Joeho I'm one of the senior biotech analysts here on the team at TD Cowan. And it's my pleasure to have with us today the team from Entrada, and DePaul Doshi, the CEO, is going to be doing, a brief presentation and then we're going to jump in with some Q&A.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Awesome. Thanks, Jeff.

All right, first and foremost, thank you to the TD Calent team for having us. We're excited to be here and, I'll
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot